American Heart Association Project Aims to Fill Guidelines Gap for Lp(a) Screening, Care Management
Novartis Pharmaceuticals has backed two cardiovascular care projects studying lipoprotein(a) in the past month: one with the American Heart Association and another with 23andMe.
In Brief This Week: Orgenesis, Merck, 23andMe, AstraZeneca, Genenta Science, GenScript
News items for the week of Feb. 27, 2023.
23andMe Gains FDA Clearance for Simvastatin Pharmacogenetic Report
The new clearance removes the need for confirmatory testing to use 23andMe's SLCO1B1 report before prescribing simvastatin for hyperlipidemia.
Genetic Testing Challenges in Oncology: Doc Tells Patient With Familial Risks to Get DTC Testing
A woman worried about her cancer risks gets tested through 23andMe upon the recommendation of a "holistic doctor" but isn't prepared for what the testing reveals.
During its R&D day, 23andMe outlined the genetics rationale for two cancer drugs it is developing and said it will apply genotyping across trials to identify best responders.